Evidence map›Paper›PMID 32793903›Full record

ArticlebioRxiv : the preprint server for biology2020

IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection.

Bruce A Rosa, Mushtaq Ahmed, Dhiraj K Singh, José Alberto Choreño-Parra, Journey Cole, Luis Armando Jiménez-Álvarez, Tatiana Sofía Rodríguez-Reyna, Bindu Singh, Olga Gonzalez, Ricardo Carrion and 6 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 25 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Bruce A RosaDepartment of Medicine, Washington University in St. Louis, St. Louis, MO 63110.
Mushtaq AhmedDepartment of Molecular Microbiology, Washington University in St. Louis, St. Louis, MO 63110.
Dhiraj K SinghSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78245.
José Alberto Choreño-ParraEscuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Journey ColeSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78245.
Luis Armando Jiménez-ÁlvarezLaboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Tatiana Sofía Rodríguez-ReynaDepartment of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Bindu SinghSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78245.
Olga GonzalezSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78245.
Ricardo CarrionSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78245.
Larry S SchlesingerSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78245.
John MartinDepartment of Medicine, Washington University in St. Louis, St. Louis, MO 63110.
Joaquín ZúñigaEscuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Makedonka MitrevaDepartment of Medicine, Washington University in St. Louis, St. Louis, MO 63110.
Shabaana A KhaderDepartment of Molecular Microbiology, Washington University in St. Louis, St. Louis, MO 63110.
Deepak KaushalSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78245.
Texas Biomedical Research Institute · USWashington University in St. Louis · USInstituto Nacional de Enfermedades Respiratorias · MXInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXInstituto Politécnico Nacional · MX

Funding

Viral Testing CoreU42OD010442 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Deepak Kaushal · 2012 to 2026
$35.6M
The Role of Group 3 Innate Lymphoid cells (ILC3) in TuberculosisR01AI134236 · NIAID · WASHINGTON UNIVERSITY · PI COLONNA, MARCO, KHADER, SHABAANA A. · 2017 to 2021
$4.4M
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANSR01AI123780 · NIAID · WASHINGTON UNIVERSITY · PI KAUSHAL, DEEPAK, KHADER, SHABAANA A. · 2016 to 2019
$2.9M
NIAID NIH HHS R01 AI123780NIAID NIH HHS R01 AI134236NIH HHS U42 OD010442
6 · The paper itself

Abstract

The novel virus SARS-CoV-2 has infected more than 14 million people worldwide resulting in the Coronavirus disease 2019 (COVID-19). Limited information on the underlying immune mechanisms that drive disease or protection during COVID-19 severely hamper development of therapeutics and vaccines. Thus, the establishment of relevant animal models that mimic the pathobiology of the disease is urgent. Rhesus macaques infected with SARS-CoV-2 exhibit disease pathobiology similar to human COVID-19, thus serving as a relevant animal model. In the current study, we have characterized the transcriptional signatures induced in the lungs of juvenile and old rhesus macaques following SARS-CoV-2 infection. We show that genes associated with Interferon (IFN) signaling, neutrophil degranulation and innate immune pathways are significantly induced in macaque infected lungs, while pathways associated with collagen formation are downregulated. In COVID-19, increasing age is a significant risk factor for poor prognosis and increased mortality. We demonstrate that Type I IFN and Notch signaling pathways are significantly upregulated in lungs of juvenile infected macaques when compared with old infected macaques. These results are corroborated with increased peripheral neutrophil counts and neutrophil lymphocyte ratio in older individuals with COVID-19 disease. In contrast, pathways involving VEGF are downregulated in lungs of old infected macaques. Using samples from humans with SARS-CoV-2 infection and COVID-19, we validate a subset of our findings. Finally, neutrophil degranulation, innate immune system and IFN gamma signaling pathways are upregulated in both tuberculosis and COVID-19, two pulmonary diseases where neutrophils are associated with increased severity. Together, our transcriptomic studies have delineated disease pathways to improve our understanding of the immunopathogenesis of COVID-19 to facilitate the design of new therapeutics for COVID-19.

Identifiers

PMID32793903
PMCPMC7418717
OpenAlexW3047249308

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.